Omalizumab for successful chemotherapy desensitisation: What we know so far.

Bumbacea, Roxana Silvia; Ali, Selda; Corcea, Sabina Loredana; Spiru, Luiza; Nitipir, Cornelia; Strambu, Victor; Bumbacea, Dragos

Bumbacea, Roxana Silvia; Ali, Selda; Corcea, Sabina Loredana; Spiru, Luiza; Nitipir, Cornelia; Strambu, Victor; Bumbacea, Dragos.

Afiliación

Bumbacea RS; "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.
Ali S; Department of Allergy and Clinical Immunology "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest Romania.
Corcea SL; "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.
Spiru L; Department of Allergy and Clinical Immunology "Dr. Carol Davila" Nephrology Clinical Hospital Bucharest Romania.
Nitipir C; Novomedica Center of Excellence Bucharest Romania.
Strambu V; "Carol Davila" University of Medicine and Pharmacy Bucharest Romania.
Bumbacea D; The Excellence Memory Center and Longevity Medicine "Ana Aslan" International Foundation Bucharest Romania.

Clin Transl Allergy ; 11(10): e12086, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34938440

Palabras clave

chemotherapy hypersensitivity; drug desensitisation; omalizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Transl Allergy Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google